|
Disis, Mary L; Bernhard, Helga; Jaffee, Elizabeth M (2009) Use of tumour-responsive T cells as cancer treatment. Lancet 373:673-83
|
|
Emens, Leisha A (2008) Chemotherapy and tumor immunity: an unexpected collaboration. Front Biosci 13:249-57
|
|
Manning, Elizabeth A; Ullman, John G M; Leatherman, James M et al. (2007) A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism. Clin Cancer Res 13:3951-9
|
|
Prendergast, George C; Jaffee, Elizabeth M (2007) Cancer immunologists and cancer biologists: why we didn't talk then but need to now. Cancer Res 67:3500-4
|
|
Emens, L A; Reilly, R T; Jaffee, E M (2005) Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity. Endocr Relat Cancer 12:1-17
|
|
Ercolini, Anne M; Ladle, Brian H; Manning, Elizabeth A et al. (2005) Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med 201:1591-602
|
|
Laheru, Dan A; Pardoll, Drew M; Jaffee, Elizabeth M (2005) Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology. Mol Cancer Ther 4:1645-52
|
|
Emens, Leisha A; Jaffee, Elizabeth M (2005) Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. Cancer Res 65:8059-64
|
|
Emens, Leisha A; Reilly, R Todd; Jaffee, Elizabeth M (2004) Augmenting the potency of breast cancer vaccines: combined modality immunotherapy. Breast Dis 20:13-24
|
|
Ercolini, Anne M; Machiels, Jean-Pascal H; Chen, Yi Cheng et al. (2003) Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice. J Immunol 170:4273-80
|
Showing the most recent 10 out of 32 publications
